[The stream is slated to start at 11 a.m. ET. Please refresh the page if you do not see a player above at that time.]
A Centers for Disease Control and Prevention advisory panel is meeting Thursday to discuss a serious, but rare, autoimmune disorder linked to Johnson & Johnson‘s Covid-19 vaccine.
The CDC’s Advisory Committee on Immunization Practices meeting comes a little over a week after the Food and Drug Administration announced a new warning label for the J&J shot after 100 preliminary reports of Guillain-Barre syndrome were detected in J&J recipients.
